Organization · Holding Company
CANAAN RESEARCH AND INVESTMENT
Canaan Research and Investment is a biotechnology holding company based in Alcobendas, Madrid, focusing on managing R&D projects and developing assets in the health and medical sectors.
Overview
What CANAAN RESEARCH AND INVESTMENT does
What CANAAN RESEARCH AND INVESTMENT is
Canaan Research and Investment is a biotechnology holding company based in Alcobendas, Madrid, focusing on managing R&D projects and developing assets in the health and medical sectors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Holding Company
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find CANAAN RESEARCH AND INVESTMENT elsewhere
Open the official website or a supported primary organization account.
Capability profile
CANAAN RESEARCH AND INVESTMENT as a funder
Investment thesis
Canaan Research and Investment focuses on managing R&D projects and developing biotechnology assets from public research centers, aiming to reduce commercialization risks through validated research.
Focus narrative
Canaan invests primarily in the biotechnology sector, particularly in health and medical fields. Their strategy leverages knowledge generated in public research centers to minimize project risks and optimize costs, focusing on early-stage therapeutics and biomedical R&D commercialization.
Value beyond capital
Canaan adds value to its portfolio companies by facilitating technology transfer from academia to market, utilizing validated, publicly-funded research to reduce commercialization risks and enhance project viability.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 4
Portfolio context
Canaan comprises several companies specializing in various areas of biotechnology, including: ForChronic — focusing on chronic diseases. Mirnax — likely involved in microRNA therapeutics. Derma Innovate — specializing in dermatology. Isquaemia — focusing on ischemia and cardiovascular health.
Common questions
What to know about CANAAN RESEARCH AND INVESTMENT
Upseed classifies CANAAN RESEARCH AND INVESTMENT under the Holding Company organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.